Correspondence 0001140361-23-023535 from Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc.
Date: May 8, 2023 · CIK: 0001411690 · Accession: 0001140361-23-023535
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-270459
Letter
Bionano Genomics, Inc.
9540 Towne Centre Drive, Suite 100
San Diego, California 92121
(858) 888-7600
May 8, 2023
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Jane Park
Re:
Bionano Genomics, Inc.
Registration Statement on Form S-3
File No. 333-270459
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 5:30 p.m. Eastern Time on May 10, 2023, or as soon thereafter as is practicable.
Once the above-referenced Registration Statement has been declared effective, please orally confirm that event with Phillip S. McGill of Cooley LLP, counsel to the Registrant, at (858) 550-6193.
Bionano Genomics, Inc.
By:
/s/ R. Erik Holmlin, Ph.D.
R. Erik Holmlin, Ph.D.
President and Chief Executive Officer
cc:
Phillip S. McGill, Cooley LLP
Show Raw Text
CORRESP
1
filename1.htm
Bionano Genomics, Inc.
9540 Towne Centre Drive, Suite 100
San Diego, California 92121
(858) 888-7600
May 8, 2023
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Jane Park
Re:
Bionano Genomics, Inc.
Registration Statement on Form S-3
File No. 333-270459
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced
Registration Statement on Form S-3 to become effective at 5:30 p.m. Eastern Time on May 10, 2023, or as soon thereafter as is practicable.
Once the above-referenced Registration Statement has been declared effective, please orally confirm that event with Phillip S. McGill of Cooley LLP, counsel to the Registrant, at (858) 550-6193.
Bionano Genomics, Inc.
By:
/s/ R. Erik Holmlin, Ph.D.
R. Erik Holmlin, Ph.D.
President and Chief Executive Officer
cc:
Phillip S. McGill, Cooley LLP